Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Insmed Inc (INSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,306,785
  • Shares Outstanding, K 77,539
  • Annual Sales, $ 9,840 K
  • Annual Income, $ -324,280 K
  • 60-Month Beta 3.05
  • Price/Sales 233.52
  • Price/Cash Flow N/A
  • Price/Book 10.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -1.03
  • Number of Estimates 4
  • High Estimate -0.93
  • Low Estimate -1.17
  • Prior Year -0.86
  • Growth Rate Est. (year over year) -19.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.88 +16.44%
on 02/21/19
31.50 -8.03%
on 03/14/19
+2.62 (+9.94%)
since 02/19/19
3-Month
11.31 +156.15%
on 12/24/18
31.50 -8.03%
on 03/14/19
+15.91 (+121.82%)
since 12/19/18
52-Week
11.31 +156.15%
on 12/24/18
31.58 -8.26%
on 08/03/18
+4.66 (+19.17%)
since 03/19/18

Most Recent Stories

More News
Insmed Inc Shares Up 50.0% Since SmarTrend's Buy Recommendation (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on January 7th, 2019 at $19.83. In approximately 2 months, Insmed Inc has returned 49.99% as of today's recent price of $29.75.

INSM : 28.97 (-2.62%)
Shares of INSM Up 49.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on January 7th, 2019 at $19.84. In approximately 2 months, Insmed Inc has returned 49.48% as of today's recent price of $29.65.

INSM : 28.97 (-2.62%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards...

INSM : 28.97 (-2.62%)
Insmed Inc Up 55.5% Since SmarTrend Uptrend Call (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on January 7th, 2019 at $19.84. In approximately 2 months, Insmed Inc has returned 55.48% as of today's recent price of $30.84.

INSM : 28.97 (-2.62%)
SmarTrend Watching for Potential Pullback in Shares of Insmed Inc After 1.44% Gain

Insmed Inc (NASDAQ:INSM) traded in a range yesterday that spanned from a low of $29.64 to a high of $29.96. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $29.33...

INSM : 28.97 (-2.62%)
Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of -5.41% and 96.19%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

INSM : 28.97 (-2.62%)
Insmed: 4Q Earnings Snapshot

BRIDGEWATER, N.J. (AP) _ Insmed Inc. (INSM) on Friday reported a loss of $91.6 million in its fourth quarter.

INSM : 28.97 (-2.62%)
Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the fourth quarter...

INSM : 28.97 (-2.62%)
Uptrend Call Working As Insmed Inc Stock Rises 26.8% (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on January 7th, 2019 at $19.84. In approximately 2 month, Insmed Inc has returned 26.85% as of today's recent price of $25.16.

INSM : 28.97 (-2.62%)
Watch for Insmed Inc to Potentially Rebound After Falling 3.27% Yesterday

Insmed Inc (NASDAQ:INSM) traded in a range yesterday that spanned from a low of $25.15 to a high of $25.66. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $25.81...

INSM : 28.97 (-2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade INSM with:

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

2nd Resistance Point 30.53
1st Resistance Point 29.75
Last Price 28.97
1st Support Level 28.50
2nd Support Level 28.03

See More

52-Week High 31.58
Last Price 28.97
Fibonacci 61.8% 23.84
Fibonacci 50% 21.44
Fibonacci 38.2% 19.05
52-Week Low 11.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar